Birdwatch Note Rating
2024-11-29 01:22:55 UTC - HELPFUL
Rated by Participant: 67D115C633369A03D388E950EB1D7AED06D51D75A30CFD39ADF3B52416769F85
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details